These results suggest that malignant phenotypes including radioresistance in OSCC cells can be regulated by Nrf2 antioxidant pathway, a notion supported by evidence illustrating that Nrf2-mediated antioxidation plays an important role in the development and progression of malignant tumors. The gene discussed is NFE2L2; the disease is cancer.